StemCutis Prescription Treatment

StemCutis Prescription Treatment is a topical regenerative therapy developed by StemCutis, utilizing conditioned media derived from ischemia-tolerant mesenchymal stem cells (itMSCs). This technology, licensed from Stemedica, involves culturing stem cells under hypoxic conditions to enhance the secretion of growth factors and cytokines that promote wound healing, tissue regeneration, and anti-inflammatory effects. The product is designed for topical application to treat a variety of dermatological conditions, including eczema, diabetic ulcers, cutaneous manifestations of lupus, psoriasis, and various types of scarring (hypertrophic, hypotrophic, and keloid). It also targets skin aging, dryness, and compromised skin barriers.

Other names

StemCutis Cell FactorsitMSC-derived conditioned media